"Pharmaceuticals firm Oxford Biomedica soared 5 to 23¾p on speculation that it could be taken over by partner Sanofi-Aventis. However, it is not thought that Sanofi-Aventis has any imminent plans to make a bid for the company."
http://www.telegraph.co.uk/money/main.jhtml?xml=/money/2008/02/12/cxmktrep112.xml
Tuesday, February 12, 2008
OXB
